Showing results (81-90 of 231) with videos related to
Sort By:
Pageof 24
Brain Research. Brain Research Reviews|April 6, 2004
Noradrenergic mechanisms in neurodegenerative diseases: a theoryMarc R Marien, Francis C Colpaert, Alan C RosenquistLife Sciences|January 1, 1992
Suppression of nigrostriatal and mesolimbic dopamine release in vivo following noradrenaline depletion by DSP-4: a microdialysis studyA J Lategan, M R Marien, F C ColpaertEuropean Journal of Pharmacology|May 1, 1976
Discriminative stimulus properties of benzodiazepines, barbiturates and pharmacologically related drugs; relation to some intrinsic and anticonvulsant effectsF C Colpaert, L K Desmedt, P A JanssenPsychopharmacologia|March 16, 1976
Theoretical and methodological considerations on drug discrimination learningF C Colpaert, C J Niemegeers, P A JanssenBrain Research|July 16, 1990
Effects of locus coeruleus lesions on the release of endogenous dopamine in the rat nucleus accumbens and caudate nucleus as determined by intracerebral microdialysisA J Lategan, M R Marien, F C ColpaertPsychopharmacology|July 18, 1977
Differential haloperidol effect on two indices of fentanyl-saline discriminationF C Colpaert, C J Niemegeers, P A JanssenExperimental Neurology|December 14, 2004
The novel analgesic and high-efficacy 5-HT1A receptor agonist F 13640 inhibits nociceptive responses, wind-up, and after-discharges in spinal neurons and withdrawal reflexesHao-Jun You, Francis C Colpaert, Lars Arendt-NielsenEuropean Journal of Pain (London, England)|November 9, 2004
Effects of the combined continuous administration of morphine and the high-efficacy 5-HT1A agonist, F 13640 in a rat model of trigeminal neuropathic painKristof R Deseure, Hugo F Adriaensen, Francis C ColpaertThe Journal of Pharmacy and Pharmacology|March 1, 1976
The narcotic discriminative stimulus complex: relation to analgesic activityF C Colpaert, C J Niemegeers, P A JanssenThe Journal of Pharmacology and Experimental Therapeutics|May 6, 2003
Continuous administration of the 5-hydroxytryptamine1A agonist (3-Chloro-4-fluoro-phenyl)-[4-fluoro-4-[[(5-methyl-pyridin-2-ylmethyl) -amino]-methyl]piperidin-1-yl]-methadone (F 13640) attenuates allodynia-like behavior in a rat model of trigeminal neuropathic painKristof Deseure, Wouter Koek, Hugo Adriaensen, et al.Pageof 24